Cotec Healthcare Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Cotec Healthcare Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of TBD. The offering comprises a fresh issue component of TBD.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the NSE, BSE exchange.
Founded in 1998, Cotec Healthcare Limited is a pharmaceutical company operating as a Contract Development and Manufacturing Organization (CDMO) with capabilities across 24 types of formulations. The company manufactures a wide range of products such as injectables, tablets, capsules, ointments, eye drops, syrups, and infusions, covering multiple therapeutic areas including pain relief, antibiotics, cardiovascular care, dermatology, women’s health, nutrition, and supplements. Its manufacturing facility is located in Roorkee, Uttarakhand, with a large production capacity of over 4,000 million units as of March 31, 2025. Cotec serves a broad customer base, including well-known pharma companies, and operates across both domestic and international markets, supplying products across India and exporting to several countries. The company is also planning to expand its global presence into new regions like Central Asia, Africa, and Europe. As of August 31, 2025, it had 419 permanent employees along with over 200 contract workers.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium is based on market buzz and online information. It should not be considered as the actual listing price or valuation. Always refer to the RHP and seek advice from a financial expert before making any investment decisions.
- Healthcare-Focused Business: Company medical / healthcare segment ma kaam kare che, je sector ma demand generally stable ane long-term growing hoy che.
- Product & Service Range: Alag-alag healthcare products ya services cover karta hova thi business ne diversification male che.
- Rising Healthcare Demand: India ma healthcare awareness ane spending vadhta hova thi growth opportunity strong che.
- Regulatory Dependency: Healthcare sector ma approvals ane compliance strict hoy, je expansion ane operations ne slow kari shake che.
- Competition Pressure: Pharma ane healthcare space ma ghana established players hoy, je thi market share maintain karvu challenging bani shake che.
- Margin Sensitivity: Pricing control, input cost ane competition na karane profitability par pressure avi shake che.
- Harsh Tiwari
- Vandana Tiwari
Cotec Healthcare Limited
Kfin Technologies Limited